• Orca Bio raises $192m to support cell therapies development pharmaceutical-technology
    June 19, 2020
    US-based biotechnology firm Orca Bio has raised $192m in a Series D financing round to support the development of cell therapies intended to provide an alternative for standard bone marrow transplants.
PharmaSources Customer Service